Vaccine delivery using nanoparticles

Vaccination has had a major impact on the control of infectious diseases. However, there are still many infectious diseases for which the development of an effective vaccine has been elusive. In many cases the failure to devise vaccines is a consequence of the inability of vaccine candidates to evoke appropriate immune responses. This is especially true where cellular immunity is required for protective immunity and this problem is compounded by the move toward devising sub-unit vaccines. Over the past decade nanoscale size (

• NI
  National Institutes of Health

  Awards: U54 AI057156, AI057156
• NI
  National Institute of Allergy and Infectious Diseases

  Award: U54 AI057156